Correction: CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia.

Guerra, Borja

Correction: CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia. [electronic resource] - Oncotarget 08 2018 - 32272 p. digital

Publication Type: Journal Article; Published Erratum

1949-2553

10.18632/oncotarget.26008 doi